Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ardea agrees with FDA on gout drug studies
Yahoo/AP
Thursday, September 8, 2011 - 11:16am
tags:
FDA, Ardea, gout, lesinurad
P&G sees emerging markets, Teva deal to fuel sales
Yahoo/AP
Thursday, September 8, 2011 - 11:16am
tags:
Teva Pharmaceuticals, P&G, emerging markets
Harvard Scientists Discover How Cancer Outwits Erbitux Drug
Bloomberg
Thursday, September 8, 2011 - 11:15am
tags:
Erbitux, Eli Lilly, breast cancer, Bristol-Myers Squibb
Keryx CEO: Selling Company 'Top Priority'
TheStreet.com
Thursday, September 8, 2011 - 11:14am
tags:
Keryx, M&A, colon cancer, perifosine
Sanofi: Another Encouraging Announcement
Seeking Alpha
Thursday, September 8, 2011 - 11:13am
tags:
Sanofi
FDA Approval Process Sets Higher Bar For What's Treatable
Seeking Alpha
Thursday, September 8, 2011 - 11:12am
tags:
FDA, AstraZeneca, JNJ, Perrigo Company, Regeneron, generics
Gilead Amends HCV Combo Study
Yahoo/Zacks.com
Thursday, September 8, 2011 - 11:11am
tags:
HCV, Gilead, hepatitis C, JNJ, GS 9190
Risk-Reward Balanced at MannKind
Yahoo/Zacks.com
Wednesday, September 7, 2011 - 1:07pm
tags:
MannKind, diabetes, Afrezza, inhaled insulin
BioMarin Evenly Poised
Yahoo/Zacks.com
Wednesday, September 7, 2011 - 1:06pm
tags:
Biomarin, Pfizer, Sanofi, Kuvan, Aldurazyme, Naglazyme, Firdapse
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wednesday, September 7, 2011 - 11:28am
tags:
Blueprint Medicines, Cerulean, Cerenis Therapeutics, Epizyme, Forma Therapeutics, Intrexon, Merrimack Pharmaceuticals, f-star, Pfenex, Pearl Therapeutics, Reata, Selecta, Rib-X Pharmaceuticals, Tesaro, Theraclone
f-star lands $708M antibody pact with Merck Serono
Fierce Biotech
Wednesday, September 7, 2011 - 11:25am
tags:
antibodies, f-star, Merck Serono
Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says
Bloomberg
Wednesday, September 7, 2011 - 11:24am
tags:
drug swap laws, Par Pharmaceutical, generics, False Claims Act
Teva defense of Copaxone starts today
Pharma Times, UK
Wednesday, September 7, 2011 - 11:20am
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis, patents
WHO Should Buy Diabetes Drugs in Bulk for Poor Nations, Novo Nordisk Says
Bloomberg
Wednesday, September 7, 2011 - 11:18am
tags:
WHO, Novo Nordisk, diabetes
AstraZeneca pushes research makeover
Boston.com, MA
Wednesday, September 7, 2011 - 11:16am
tags:
AstraZeneca, R&D
Dynavax Receives $600,000 SBIR Grant for TLR Research
Yahoo/Marketwire
Wednesday, September 7, 2011 - 11:10am
tags:
grant, Dynavax, PI3K
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wednesday, September 7, 2011 - 9:54am
tags:
Medicare, off-label, Avastin, Roche, Genentech, age-related macular degeneration
Sanofi’s PowerPoint of Doom Shows 9,500 Layoffs by the End of the Year
BNET Pharma
Wednesday, September 7, 2011 - 9:51am
tags:
Sanofi, layoffs
1 Reason the Street Should Expect Big Things From ViroPharma
Motley Fool
Wednesday, September 7, 2011 - 9:49am
tags:
ViroPharma, Gilead, Cubist Pharmaceuticals, Salix
BioDelivery Sciences reports positive Phase 1 drug results
Bizjournals.com
Wednesday, September 7, 2011 - 9:48am
tags:
BioDelivery Sciences, BEMA Buprenorphine/Naloxone, drug abuse

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.